Triple vs. dual antiplatelet therapy in patients with acute myocardial infarction and renal dysfunction.

MLA

Choi, Young Hwan, et al. “Triple vs. Dual Antiplatelet Therapy in Patients with Acute Myocardial Infarction and Renal Dysfunction.” Circulation Journal : Official Journal of the Japanese Circulation Society, vol. 76, no. 10, 2012, pp. 2405–11. EBSCOhost, https://doi.org/10.1253/circj.cj-12-0236.

APA

Choi, Y. H., Suh, S. H., Choi, J. S., Kim, C. S., Sim, D. S., Bae, E. H., Lim, S. Y., Ma, S. K., Jeong, M. H., & Kim, S. W. (2012). Triple vs. dual antiplatelet therapy in patients with acute myocardial infarction and renal dysfunction. Circulation Journal : Official Journal of the Japanese Circulation Society, 76(10), 2405–2411. https://doi.org/10.1253/circj.cj-12-0236

Chicago

Choi, Young Hwan, Sang Heon Suh, Joon Seok Choi, Chang Seong Kim, Doo Sun Sim, Eun Hui Bae, Sang Yup Lim, Seong Kwon Ma, Myung Ho Jeong, and Soo Wan Kim. 2012. “Triple vs. Dual Antiplatelet Therapy in Patients with Acute Myocardial Infarction and Renal Dysfunction.” Circulation Journal : Official Journal of the Japanese Circulation Society 76 (10): 2405–11. doi:10.1253/circj.cj-12-0236.